CA2045453A1 - Compose heterocyclique condense et composition psychopharmaceutique le contenant - Google Patents

Compose heterocyclique condense et composition psychopharmaceutique le contenant

Info

Publication number
CA2045453A1
CA2045453A1 CA2045453A CA2045453A CA2045453A1 CA 2045453 A1 CA2045453 A1 CA 2045453A1 CA 2045453 A CA2045453 A CA 2045453A CA 2045453 A CA2045453 A CA 2045453A CA 2045453 A1 CA2045453 A1 CA 2045453A1
Authority
CA
Canada
Prior art keywords
group
heterocyclic compound
condensed heterocyclic
psychopharmaceutical
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2045453A
Other languages
English (en)
Other versions
CA2045453C (fr
Inventor
Toshio Tatsuoka
Kayoko Nomura
Makoto Shibata
Masanori Kawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of CA2045453A1 publication Critical patent/CA2045453A1/fr
Application granted granted Critical
Publication of CA2045453C publication Critical patent/CA2045453C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002045453A 1990-06-28 1991-06-25 Compose heterocyclique condense et composition psychopharmaceutique le contenant Expired - Fee Related CA2045453C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2-168555 1990-06-28
JP2168555A JP2935541B2 (ja) 1990-06-28 1990-06-28 縮合複素環化合物

Publications (2)

Publication Number Publication Date
CA2045453A1 true CA2045453A1 (fr) 1991-12-29
CA2045453C CA2045453C (fr) 2000-04-25

Family

ID=15870200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002045453A Expired - Fee Related CA2045453C (fr) 1990-06-28 1991-06-25 Compose heterocyclique condense et composition psychopharmaceutique le contenant

Country Status (7)

Country Link
US (1) US5158947A (fr)
EP (1) EP0463810B1 (fr)
JP (1) JP2935541B2 (fr)
KR (1) KR920000755A (fr)
CA (1) CA2045453C (fr)
DE (1) DE69116242T2 (fr)
HU (1) HU213615B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2703408B2 (ja) * 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
JPH10504825A (ja) * 1994-08-22 1998-05-12 スミスクライン・ビーチャム・コーポレイション 二環式化合物
WO1996024594A1 (fr) * 1995-02-10 1996-08-15 Suntory Limited Derives de benzodiazepines, sels issus de ces derives, et medicaments a base de ces derives et sels
JP2001501951A (ja) * 1996-10-07 2001-02-13 スミスクライン・ビーチャム・コーポレイション 骨形成刺激方法
JP3443058B2 (ja) * 1999-11-30 2003-09-02 株式会社オーシカ アルデヒド消臭剤組成物
SE0003476D0 (sv) * 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
UA95454C2 (uk) * 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (fr) 2006-09-08 2009-06-17 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
DE102008035596A1 (de) * 2008-07-31 2010-02-04 Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts Derivate benzoannelierter Stickstoff-Heterocyclen
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE112769T1 (de) * 1988-12-28 1994-10-15 Suntory Ltd Benzoxazepinderivate.

Also Published As

Publication number Publication date
HUT60486A (en) 1992-09-28
US5158947A (en) 1992-10-27
JPH0459775A (ja) 1992-02-26
CA2045453C (fr) 2000-04-25
EP0463810B1 (fr) 1996-01-10
KR920000755A (ko) 1992-01-29
JP2935541B2 (ja) 1999-08-16
DE69116242T2 (de) 1996-06-13
HU912193D0 (en) 1991-12-30
EP0463810A1 (fr) 1992-01-02
DE69116242D1 (de) 1996-02-22
HU213615B (en) 1997-08-28

Similar Documents

Publication Publication Date Title
CA2045453A1 (fr) Compose heterocyclique condense et composition psychopharmaceutique le contenant
KR910016742A (ko) 알킬화된 옥소-피페라진일-트리아진
ID22447A (id) Senyawa gula, bahan pengegel, komposisi bahan pengegel, proses penyediaannya serta komposisi gel
CA2094773A1 (fr) Derives de 2,4-dioxo-imidazolidine
MY106309A (en) Pesticidal 1-arylimidazoles
KR890002198A (ko) 유기 규소 화합물
FI925828A0 (fi) Polyalkylenglykoler foersedda med aendgrupper
CA2053820A1 (fr) Methode d'inhibition du metabolisme du cholesterol
CA2014490A1 (fr) Composes de type diaminoethylene
KR970707122A (ko) 퀴놀린 유도체(quinoline derivative)
EP0262806A3 (fr) Composé organosilicique
AU4847497A (en) Amino resins functionalized with carbamate groups and coating composition containing the same
CA2129430A1 (fr) Diamides imidocarbonimidiques n, n'-substitues, derives d'hydroxylamines
KR940014364A (ko) 이소티아졸 유도체, 그의 제조 방법 및 용도
AU634933B1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
KR890017309A (ko) 실온 경화성 조성물
CA2188924A1 (fr) Derives d'arylpiperidine et d'arylpiperazine et medicaments contenant lesdits derives
CA2010217A1 (fr) Composes d'aralkylamine
TR199901301T2 (xx) Yeni eritromisin t�revleri ve bunlar�n haz�rlanma y�ntemi.
DK606286A (da) Anthracyclin-derivater og laegemidler indeholdende disse forbindelser
IE40395L (en) 2,3- dihydrobenzofuranyl -7-n-methylcarbamates;¹insecticides
JPS5712420A (en) Magnetic recording medium
CA2045717A1 (fr) Composition lubrifiante
CA2004277A1 (fr) Composes antirouille et anticorrosion
KR840007002A (ko) β-락탐 유도체의 제조방법

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed